Dean L. Winslow

Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure

Chanu Rhee, Kathleen Chiotos, Sara E. Cosgrove et al. · Clinical Infectious Diseases · 2020 · 196 citations · Full text

Severe Sepsis, Possible Sepsis, Infectious Diseases Society +19

Characterization of human immunodeficiency virus type 1 mutantswith decreased sensitivity to proteinase inhibitor Ro 31-8959

Helmut Jacobsen, Kaya Yasargil, Dean L. Winslow et al. · Virology · 1995 · 190 citations

Viral Replication, Human Retrovirus, Pathogenesis +10

Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic Millimeter

Louis D. Saravolatz, Dean L. Winslow, Gary Collins et al. · New England Journal of Medicine · 1996 · 175 citations · Full text

Cyclic HIV Protease Inhibitors:  Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity Relationship, and Molecular Recognition of Cyclic Ureas

Patrick Y. S. Lam, Yu Ru, Prabhakar K. Jadhav et al. · Journal of Medicinal Chemistry · 1996 · 170 citations · Full text

Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450

C. Nicholas Hodge, Paul E. Aldrich, Lee T. Bacheler et al. · Chemistry & Biology · 1996 · 148 citations · Full text

Hiv-1 Protease, Biochemistry, Medicine +9